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In 1991, the National Academy of Sciences (NAS) published a report, Monitoring Human Tissues for Toxic Substances, which presented a summary
of thinking about the banking of human tissue specimens at the time the report was completed. The present article summarizes the findings and
recommendations in the NAS report. Events have moved very rapidly since that time, but some history may be helpful in understanding how we
have come to where we are today. - Environ Health Perspect 103(Suppl 3):81-84 (1995)
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In 1991 the National Academy ofSciences
(NAS) released a report entitled
Monitoring Human Tissues for Toxic
Substances (1). That report, in language as
well as substance, is the basis for most of
my comments here and should be con-
sulted by readers who want more detail or
references. I had the privilege of chairing
the committee that wrote the report. Other
members were David Gaylor, William
Grizzle, Thomas Grumbly, David Kalman,
Kathryn Mahaffey, H.B. Matthews,
Frederica Perera, and Joseph Waksburg. I
have tried to interpret the report in light of
changes since it was published and to
approximate what these committee mem-
bers might say today, but readers should
understand that I may have erred.
The report is still less than 4 years old,
but many of its recommendations have
already been implemented Joseph Carra to
James Reisa, personal communication). In
addition, concepts and procedures have
advanced so rapidly-stimulated in part by
the report itself-that the new breadth and
richness of understanding make parts of it
seem out ofdate. Thus the present article is
to some extent a historical record of how
we came to the status reported at this
conference.
This paper was presented at the Conference on
Human Tissue Monitoring and Specimen Banking:
Opportunities for Exposure Assessment, Risk
Assessment, and Epidemiologic Research held
30 March-1 April 1993 in Research Triangle Park,
North Carolina.
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Many toxic substances in the environ-
ment, including synthetic chemicals, pose
hazards to human health, but monitoring
human exposures can be difficult. Many
substances move readily from one environ-
mental medium to another, and reliable
monitoring data are sparse for most routes
of human exposure. Furthermore, moni-
toring the environment by identifying and
measuring concentrations of chemicals in
environmental media (e.g., air, water, and
soil) is not by itself an adequate basis for
assessing human exposures.
Determining the concentrations ofspe-
cific chemicals in human tissues, such as
blood and adipose tissue, can serve in effect
to integrate many kinds of human expo-
sures across media and time. A
well-designed national program to monitor
toxic chemicals in human tissues is a neces-
sary component of an anticipatory strategy
aimed at early identification of and
response to health and environmental
problems concerning xenobiotic toxicants
in the environment.
The National Human Monitoring
Program (NHMP) was established in 1967
within the U.S. Public Health Service to
study changes in pesticide residues in the
U.S. population. The primary activities of
the NHMP have been the National
Human Adipose Tissue Survey (NHATS)
and special studies to support other pro-
grams requiring data relevant to chemical
exposures. The NHMP, including
NHATS, was transferred to the
Environmental Protection Agency (U.S.
EPA) in 1970. Since 1981, the NHMP has
been the responsibility of the U.S. EPA's
Office ofToxic Substances (OTS).
The NHATS was redesigned by OTS
to identify chemicals to which a representa-
tive sample of the U.S. population was
being exposed, to establish baselines and
trend data on chemicals for toxicologic
testing, to identify populations at risk and
set priorities for risk reduction, and to help
assess the effects of regulation. To accom-
plish these goals, the NHATS measured
residues ofchemicals in human adipose tis-
sue. Up to 1991, the NHATS had col-
lected approximately 12,000 samples of
adipose tissue-85 to 90% from autopsied
cadavers and the remainder from surgical
patients. Tissues were obtained through a
national network ofpathologists and med-
ical examiners from 47 urban regions or
metropolitan statistical areas (MSAs); no
rural areas or small towns outside MSAs are
included. In recent years, the number of
specimens collected has dropped from an
annual quota of 1370 in the early 1970s to
500 to 800 in the 1980s.
The NHATS successfully documented
widespread and significant prevalence of
pesticide exposures in the general popula-
tion. It also showed that reduced use of
polychlorinated biphenyls (PCBs), DDT,
and dieldrin resulted in lower tissue con-
centrations of these compounds. A trend
analysis for 1978 to 1981 showed a dra-
matic decline in PCB concentrations after
the regulation ofPCBs in 1976.
When the NHATS program began
some 20 years ago, it used state-of-the-art
procedures in pesticide analysis in human
tissues. However, while the objectives of
the program developed and grew, program
design and support did not keep pace.
Design and management problems were
compounded by insufficient financial
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support for the changing and expanding
objectives, and the overall quality of the
NHATS deteriorated. It was recently sus-
pended, in part as a result ofthe committee
report.
The NAS committee determined that
an ideal national human monitoring pro-
gram should do the following:
* Measure concentrations of known
chemical contaminants in human tis-
sues and help identify new or previously
unrecognized hazards related to chemi-
cal substances found in the environ-
ment, especially those resulting from
human activities.
* Establish trends in body burdens oftox-
icants that result from changes in man-
ufacture, use, and disposal patterns, and
thus monitor the results of programs
intended to control specific chemical
hazards.
* Provide biologic samples and data to
aid in the evaluation of relationships
between environmental exposure and
toxic effects for purposes of risk
assessment.
* Identify population groups (by age,
geographic location, etc.) that might be
at risk because ofhigh bodyburdens.
* Provide data for comparison with
results of complementary environmen-
tal monitoring programs.
* Provide human tissues essential for
research on related matters, such as
determination ofbody burdens; distrib-
ution ofchemicals among body com-
partments; identification of biologic
markers; and procurement, storage, and
analysis ofhuman tissues.
* Allow assessment of past exposure to
newly identified toxicants.
Thus the committee considered both of
the major arms of a monitoring program:
collection of tissues for analyses ofpresent
interest, and banking of tissues for future
study of problems not yet well defined.
The committee came to 30 conclusions
and recommendations. Some had to do
with the program now suspended, and oth-
ers focused on matters oflimited relevance
outside the U.S. EPA. Some of those of
broader and continuing interest are as
follows, lightly edited.
The committee strongly supports a
United States population tissue monitoring
program.
Given the central role of chemicals in
modern society, people will be exposed to
chemicals. It is prudent that the general
population be monitored to aid in assessing
magnitudes ofexposures and to determine
the need for and effectiveness of regula-
tions and other measures to limit risk.
Although tissue-monitoring data alone
can signal a need to conduct studies on
specific environmental chemicals, tissue
monitoring to indicate past exposures to
chemicals in the environment is best
viewed as one component ofa comprehen-
sive environmental monitoring program.
Information on chemical toxicity typically
is inadequate; even if it were adequate,
planned and unplanned releases of toxic
substances would still change human
exposures.
The quantities ofchemicals present in
various media can be used to determine
which of those media may be potential
routes ofexposure; however, such measure-
ments are not necessarily reflected in tissue
concentrations. Tissue chemical measure-
ments must be supplemented with knowl-
edge ofcontaminant sources, environmental
pathways, environmental concentrations,
time patterns and locations of exposure,
routes of entry into the body, material
toxicity, and latency.
It is not feasible to study a broad range
of tissues in a general population sample.
Instead, attempts must be made to identify
tissues that most nearly account for the
body burden of most ofthe chemicals of
concern. When the NHATS was designed,
pesticides were of greatest concern, espe-
cially chlorinated aromatic hydrocarbons,
which tend to accumulate in adipose tis-
sues. New trends in environmental expo-
sures, advances in analytic chemistry,
increased sensitivity ofequipment, and the
discontinuation of the use of most halo-
genated aromatic hydrocarbons as pesti-
cides and many halogenated aromatic
industrial chemicals make the study of
other tissues important as well as feasible.
The committee considered the collection
ofblood as well as other tissues and speci-
mens, including lean tissue, hair, urine,
and some other biologic fluids.
The present evidence led the committee
to conclude that the basis of a human-
tissue monitoring program should be
broad, random collection ofblood samples,
supplemented by the continued collection
ofadipose tissue.
While blood and adipose tissue are
being collected, the program should under-
take research on how the chemical measure
ofaxenobiotic toxicant in one tissue is cor-
related with that in another, so that the
effects of nonrandomness in the adipose
samples will be better understood and the
continued contribution of the adipose
samples (including stored samples) can be
evaluated properly.
Regardless ofthe tissues collected, sam-
ples should be accompanied by standard-
ized information on demographics, illness
(especially terminal illness), and known
occupational or other major exposures to
chemicals.
High priority should be given to the
collection ofmatched adipose and blood
specimens for future parallel analyses.
Matched specimens of fat from different
anatomic regions also might be useful.
If the NHATS were replaced, as the
committee recommends, with a blood
monitoring program as the primary
method of measuring toxic substances in
human tissue, the sampling plan should be
patterned after the one used in National
Health and Nutrition Examination Survey,
which includes a close approximation to a
probability sample ofthe U.S. population.
Blood specimens should be collected in
strict accordance with the method ofprob-
ability sampling at all stages. The methods
used should be efficient for giving virtually
all persons in the United States a known
probability ofselection.
Such a system also would permit inter-
views with the sampled persons to obtain
data on covariates.
Many authorities in environmental
monitoring believe that a prospectively
designed tissue bank should accompany
environmental monitoring programs,
although retrospective analysis is still an
important function for an archive. Banked
specimens and separately obtained speci-
mens can reveal trends in environmental
chemical exposure and identify agents
responsible for pathophysiologic changes in
humans, plants, and animals.
The goals ofa program to bank human
tissues, operated in parallel with an envi-
ronmental monitoring program, should be
clear and supported-with a long-term
commitment-by the organization spon-
soring the program. Such a specimen bank
will have many purposes and must support
those purposes. The utility ofa tissue bank
depends on its correct operation; its
resources; and the proper selection, collec-
tion, handling, and storage ofspecimens.
The committee advises the archiving of
newly collected specimens according to
state-of-the-art protocols.
While a chemical analysis may begin
with a mixture of subsamples of tissues
("composited samples"), the specimens
themselves should be collected and stored
in a manner that preserves the possibility
of basing measurements on individual
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samples; and a substantial part ofthe new
program should be based on individual
analyses. When it can be shown explicitly
that values based on individual samples are
not needed, some degree of compositing
might be appropriate.
"Monitoring" implies routine measure-
ment that is inherently closed ended and
based on established methods and prac-
tices. Requirements and approaches for
monitoring programs vary, but usually pro-
ceed from a list ofanalytes (target chemi-
cals) and assay methods that have been
validated for the sample type and concen-
tration range ofinterest. Asuccessful moni-
toring program maintains results over time
for comparison and must, therefore, be
technically adequate at the outset.
Comparability is most easily achieved if
assay methods are constant. The committee
considered the following aspects ofa moni-
toring program in its deliberations:
* Present knowledge does not permit des-
ignation ofall substances that might be
detectable in tissues or that would be
important ifdetected.
* Present analytic technology is inade-
quate for surveillance ofsome chemicals
because of limitations in sensitivity,
applicability, and cost.
* The importance of individual target
chemicals will increase or decrease over
time, but slowly. "Emergency" exposure
assessments that might be required
when a serious health hazard is discov-
ered would be addressed best byfocused
special studies.
* Monitoring efforts will provide oppor-
tunities for exploration oftissue compo-
sition beyond a list oftarget chemicals.
Those opportunities and other efforts
parallel to the monitoring tasks should
support continuing development ofthe
monitoring program itself.
Once the relative importance ofvarious
possible uses of the data has been estab-
lished, rationales for selecting target chemi-
cals should be incorporated into a systemic
weighting scheme and applied as compre-
hensively as feasible.
Criteria for determining the relative
importance ofa candidate target chemical
should be separated from issues ofanalytic
feasibility until late in the planning effort.
Identification of one or more analytes that
might require a new assay protocol would
be important in planning future method
development.
Design ofan adaptable monitoring pro-
gram with mechanisms for selection ofnew
analytes, and for the development and
validation of methods for collection,
storage, and assay will permit a monitoring
program to remain responsive to changing
needs and to take advantage ofprogress in
analytic technology in an organized fashion.
Interpretation offindings in relation to
larger program goals (such as time trends,
efficacy of interventions, relative impor-
tance ofdifferent environmental contami-
nants, and regional or demographic
differences in exposures) is an important
part of understanding and meeting
additional data needs.
A monitoring program must be able to
articulate and influence research priorities
for development of new analytic applica-
tions of emerging technology and to
benefit from new developments.
Priority should be given to setting and
maintaining a regular schedule for analysis
ofresults ofeach assay type.
Organizational and administrative loca-
tion of a human-tissue monitoring pro-
gram is critical. The selection ofan agency
to lead national surveillance of chemical
exposures is not simple. Although a suc-
cessful monitoring program must be rele-
vant to regulatory needs, it could and should
serve a wide range of client programs,
without being dominated by any one.
The committee had specific concerns
about the untoward effects of placing a
monitoring program in any subunit with
direct, major regulatory responsibilities.
The committee firmly recommends
that monitoring be kept strictly indepen-
dent ofregulation itself.
The committee concludes that consid-
erations of input to policy, impact, visibil-
ity, and independence argue for a location
at the highest feasible organizational level.
A location that is geographically close
to other programs and laboratories active in
relevant technical disciplines would facili-
tate important exchanges about methods,
as well as follow-up offindings.
The critical resources in a program of
monitoring human tissues include funding
and expertise in appropriate scientific
fields. Sufficient funding, with assurance
that it will remain adequate over the next
few years, is essential. However, the final
budget for a program should be deter-
mined after the program specifications have
been formulated. The major factors
involved in determining funding are the
annual sample size, the set of chemical
assays to be performed, the type oftissue to
be collected, the size ofthe staff needed to
monitor the program and analyze results,
and requirements for research and develop-
ment. Funding is flexible to a certain point.
However, there is a minimum level of
funding below which the program would
not be worthwhile; and obviously, the
greater the funding, the more informative
the analyses that can be conducted.
Although the committee did not under-
take detailed cost analyses, it believed that
the U.S. EPA's history as well as the opera-
tion of other tissue-monitoring programs
suggest that $5 million per year, exclusive
ofstaff salaries and overhead, could sup-
port a substantial flow ofhigh-quality, pol-
icy-relevant information. This level still is
not munificent support, but it might be
sufficient to serve U.S. EPA's policy needs
and bring some critical distinction to the
program. Furthermore, it could be used to
develop a solid base ofcompetence, experi-
ence, and usefulness to support possible
expansion in the future.
Greater financial support-even up to
the 25 to $50 million per year suggested by
heads of other agencies-could be put to
good use, given appropriate planning and
the organizational setting and mission
described in the NAS report. However,
such allocations did not appear feasible at
that time, so the committee did not explore
their implications.
The committee recommends strong
and continuing oversight of the new
human-tissue monitoring program.
Expert advice can be obtained in several
ways, but the numerous criteria required to
establish and maintain a human-tissue
monitoring program point strongly to a
standing, outside, scientific advisory body
to advise both the program staff and its
parent institution.
Nearly all members of such a body
should be knowledgeable in detail about
one or more scientific and technical disci-
plines important to the program. Advice
provided by this group would include over-
sight ofprogram content, program manage-
ment, program planning, resource needs,
technical operations, timeliness, and appro-
priate dissemination ofresults. The advisory
body should have no other major responsi-
bilities related to the program. The com-
mittee envisions quarterly meetings that
would taper rapidly to annual meetings.
Details ofprogram structure and orga-
nization depend heavily on a host ofman-
agement decisions that the committee
could not foresee. Some of the issues that
must be considered, however, include
in-house scientific and managerial compe-
tence; professional staffmembers fully ded-
icated to human-tissue monitoring; and
program design.
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Some professional staffmembers should
be fully dedicated to the program, without
competing duties.
The committee specifically recommends
that the program be designed in a modular
fashion as much as possible to permit criti-
cal core activities to be maintained even if
other activities must be curtailed, sus-
pended, or ended at some future time.
A structured approach to basic and
more exploratory data analysis is needed.
The plan for each year's monitoring effort
should include a data-analysis plan, with
analytic subprojects. Well-defined analyses
should result in early reporting offindings;
analyses that require method development
or input that is not in the chemical analysis
set might be reported less rapidly or less
often. At a minimum, however, descriptive
summary analyses of the data should
appear with the same frequency as the
chemical analyses.
Data from human-tissue monitoring
cannot, in general, be fully interpreted
without other information regarding tissue
concentrations, patterns ofexposures, and
the metabolism and toxicology ofindivid-
ual chemicals. Reporting ofthose should be
systematized, with close collaboration
between the statistical analysts and persons
providing other information. Comparison
data, especially reports of tissue concentra-
tions ofchemical agents, should be sought
continuously. Strong interagency and
intra-agency collaboration in planning and
exchange ofdata will be required to address
measurement objectives, facilitate the
analysis of monitoring-program results,
and develop a program that well be most
useful to cooperating agencies.
The program must produce timely
reports regularly.
The committee recommends that at a
minimum, an annual report ofbasic analy-
ses should be produced within a year of
completion ofthe sample collection.
Reports should, and almost certainly
will, undergo internal review. Extra-agency
review of draft reports is also desirable,
especially peer review by persons on the sci-
entific advisory panel and perhaps other
persons with specific expertise.
A human-tissue monitoring program
should be designed as a multiple-user ser-
vice activity. That creates substantial oblig-
ations for assisting users to understand
what the program does and does not pro-
vide, for timely analysis and publication of
results, for specific and helpful guidance in
access to archived specimens, and for active
"marketing" ofproducts, that is, promot-
ing the use ofboth data and specimens.
A well-defined process for producing a
range ofoutputs is an important part ofthe
planning effort. A schedule should be
widely and continually publicized and
should be relaxed only under the most
compelling circumstances. Scientific staff,
who bear most of the responsibility for
meeting a schedule, should recognize that
timely, high-quality reports on important
matters are a sine qua non.
A specific person or persons must be
responsible for outreach efforts, which are
warranted by the multiuse nature of the
program, the wide-ranging interest in the
resulting data, and the clear indications
that more passive approaches to publicizing
program reports have failed to reach some
critical target groups.
A tissue-monitoring and archival pro-
gram must cooperate and communicate
with other branches ofU.S. EPA, other gov-
ernment agencies, academic and private sec-
tors, and foreign environmental programs.
Not only are such cooperation and informa-
tion exchanges important in the operation
ofhuman-tissue monitoring, but continuing
information exchange will be critical to the
efficient operation ofthe new program.
The committee concluded that special
value might be found in the joint develop-
ment ofa small set of measurements to be
made in similar ways across a broad range
of programs, as a means of establishing
comparability among programs that could
lead to a worldwide database for environ-
mental toxicants that persist over long
times or migrate across long distances and
across national boundaries.
It is heartening to see the progress that
has already been made toward the develop-
ment of a program for monitoring toxic
substances in human tissues.
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